Network origin in Julien Mamet first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
11
| Public Company | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julien Mamet via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Operating Officer Chief Operating Officer Comptroller/Controller/Auditor | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Founder Founder General Counsel | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
RightCare Solutions, Inc.
 RightCare Solutions, Inc. Packaged SoftwareTechnology Services Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA. | Packaged Software | Director/Board Member Director/Board Member Chief Operating Officer | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| McGill University | College/University | Masters Business Admin Undergraduate Degree | |
| Stone Sunny Isles, Inc. | Chief Executive Officer | ||
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Chairman | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman | |
Bicycle Therapeutics, Inc.
 Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Pharmaceuticals: Major | Chairman | |
BicycleTx Ltd.
 BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
| Dartmouth College | College/University | Undergraduate Degree | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman | |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Financial Conglomerates | Chief Executive Officer | |
| HEC Montréal | College/University | Undergraduate Degree | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
Interfonction Ltd.
 Interfonction Ltd. Building ProductsProducer Manufacturing Part of Interfonction Ltd., Interfonction is a Canadian company that manufactures aluminum and glass interior doors. The company is based in Sherbrooke, Canada. The company was founded in 1990 by Pierre Legault. The CEO is Johanne Tousignant. Interfonction was acquired by Interfonction /Private Group/ on December 31, 2014. | Building Products | Founder | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member | |
Eckerd Corp.
 Eckerd Corp. Drugstore ChainsRetail Trade Part of Rite Aid Corp., Eckerd Corp. is a company that owns and operates drugstores. The company is based in Largo, FL. | Drugstore Chains | Chief Executive Officer | |
Semprae Laboratories, Inc.
 Semprae Laboratories, Inc. Medical/Nursing ServicesHealth Services Semprae Laboratories, Inc. provides consumer products for female sexual health. The company was founded by Rachel Braun Scherl and Mary Wallace Jaensch in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Chairman | |
| POXEL | Pharmaceuticals: Major | Chairman | |
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| Saint Mary's University | College/University | Masters Business Admin | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Stone Management LLC
 Stone Management LLC Miscellaneous Commercial ServicesCommercial Services Stone Management LLC provides management services. | Miscellaneous Commercial Services | Chief Executive Officer | |
| NEPHROGENEX INC | Medical Distributors | Chief Executive Officer | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chairman | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 36 |
| United Kingdom | 7 |
| Canada | 6 |
| France | 5 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 84 |
| Chief Executive Officer | 38 |
| Chairman | 36 |
| Corporate Officer/Principal | 27 |
| President | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Pierre Legault | 45 |
| Dennis Podlesak | 27 |
| David Ian Johnson | 15 |
| Stanley Abel | 13 |
| Rick Orr | 11 |
| Matthew Ruth | 11 |
| Gregory Flesher | 9 |
| Donald C. Manning | 8 |
| William Martin | 4 |
| Dina Gonzalez | 4 |
- Stock Market
- Insiders
- Julien Mamet
- Company connections
